Quest Diagnostics Overview
Quest Diagnostics Target Price
Analysts' 12-month price predictions for DGX.
Share Price
$174.49
Average Target Price
$186.50
6.9% upside
6.9% upside4 analysts in the last 4 months
High: $195 | Low: $180
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-02 | Redburn PartnersJamie Clark | $195 | 11.8% upside |  |
| 2025-02-03 | Piper SandlerDavid Westenberg | $180 | 3.2% upside | |
| 2025-01-31 | Truist FinancialDavid MacDonald | $182 | 4.3% upside | |
| 2025-01-31 | Robert W. BairdEric Coldwell | $189 | 8.3% upside | |
| 2024-10-23 | CitigroupPatrick Donnelly | $185 | 6% upside | |
| 2024-10-23 | Leerink PartnersMichael Cherny | $165 |  5.4% downside | |
| 2024-10-23 | BarclaysStephanie Davis | $168 | 3.7% downside | |
| 2024-10-23 | Robert W. BairdEric Coldwell | $182 | 4.3% upside | |
| 2024-10-22 | CFRAPaige Meyer | $178 | 2% upside | |
| 2024-10-07 | Truist FinancialDavid MacDonald | $165 | 5.4% downside | |
| 2024-07-29 | Mizuho SecuritiesAnn Hynes | $160 | 8.3% downside | |
| 2024-07-24 | Robert W. BairdEric Coldwell | $154 | 11.7% downside | |
| 2024-07-15 | Truist FinancialDavid MacDonald | $158 | 9.5% downside | |
| 2024-04-25 | BarclaysStephanie Davis | $144 | 17.5% downside | |
| 2024-02-07 | JefferiesBrian Tanquilut | $155 | 11.2% downside | |
| 2023-02-03 | Wells Fargo | $140 | 19.8% downside | |
| 2023-01-06 | Morgan Stanley | $158 | 9.5% downside | |
| 2022-11-17 | Citigroup | $125 | 28.4% downside | |
| 2022-05-03 | Morgan Stanley | $142 | 18.6% downside | |
| 2022-04-25 | Wells Fargo | $150 | 14% downside | |
| 2022-04-09 | CitigroupRalph Giacobbe | $175 | 0.3% upside | |
| 2022-01-15 | Deutsche BankPito Chickering | $190 | 8.9% upside | |
| 2021-12-13 | KeyBancDonald Hooker | $170 | 2.6% downside | |
| 2021-09-09 | Credit SuisseA.J. Rice | $150 | 14% downside | |